Business Description
Bangkok Dusit Medical Services PCL
NAICS : 622110
ISIN : US05989Q1067
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.52 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 0.72 | |||||
Interest Coverage | 34.56 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.66 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14 | |||||
3-Year EBITDA Growth Rate | 12.3 | |||||
3-Year EPS without NRI Growth Rate | 38.6 | |||||
3-Year FCF Growth Rate | 35.3 | |||||
3-Year Book Growth Rate | 2.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 13.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 8.13 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.91 | |||||
9-Day RSI | 21.79 | |||||
14-Day RSI | 35.91 | |||||
6-1 Month Momentum % | 7.76 | |||||
12-1 Month Momentum % | 7.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.28 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 12.47 | |||||
Days Sales Outstanding | 36.78 | |||||
Days Payable | 29.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.43 | |||||
Dividend Payout Ratio | 0.74 | |||||
3-Year Dividend Growth Rate | 29.4 | |||||
Forward Dividend Yield % | 2.43 | |||||
5-Year Yield-on-Cost % | 4.5 | |||||
Shareholder Yield % | 2.49 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.12 | |||||
Operating Margin % | 18.73 | |||||
Net Margin % | 14.25 | |||||
FCF Margin % | 12.4 | |||||
ROE % | 15.61 | |||||
ROA % | 10.15 | |||||
ROIC % | 12.38 | |||||
ROC (Joel Greenblatt) % | 20.56 | |||||
ROCE % | 15.79 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.46 | |||||
Forward PE Ratio | 28.01 | |||||
PE Ratio without NRI | 31.53 | |||||
Shiller PE Ratio | 37.28 | |||||
Price-to-Owner-Earnings | 31.71 | |||||
PEG Ratio | 13.14 | |||||
PS Ratio | 4.41 | |||||
PB Ratio | 4.67 | |||||
Price-to-Tangible-Book | 5.87 | |||||
Price-to-Free-Cash-Flow | 35.67 | |||||
Price-to-Operating-Cash-Flow | 21.41 | |||||
EV-to-EBIT | 23.63 | |||||
EV-to-Forward-EBIT | 29.84 | |||||
EV-to-EBITDA | 18.11 | |||||
EV-to-Forward-EBITDA | 21.43 | |||||
EV-to-Revenue | 4.5 | |||||
EV-to-Forward-Revenue | 4.17 | |||||
EV-to-FCF | 36.37 | |||||
Price-to-Projected-FCF | 2.63 | |||||
Price-to-DCF (Earnings Based) | 2.66 | |||||
Price-to-DCF (FCF Based) | 1.24 | |||||
Price-to-Median-PS-Value | 0.88 | |||||
Price-to-Graham-Number | 2.87 | |||||
Earnings Yield (Greenblatt) % | 4.23 | |||||
FCF Yield % | 2.8 | |||||
Forward Rate of Return (Yacktman) % | 2.85 |